ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,862Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 393

$726K Total Retail Price of All Prescriptions

Rank: 21 out of 393

629 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 629 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 629 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 9,869 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 629 595 1 1
LEVOTHYROXINE SODIUM 619 542 2 3
LISINOPRIL 438 430 3 2
AMLODIPINE BESYLATE 402 392 4 4
OMEPRAZOLE 336 313 5 6
ZOLPIDEM TARTRATE 297 280 6 11
HYDROCODONE-ACETAMINOPHEN 261 206 S3 7 5
GABAPENTIN 201 174 8 15
HYDROCHLOROTHIAZIDE 200 193 9 10
ALLOPURINOL 189 189 10 26
CARVEDILOL 179 167 11 21
ATORVASTATIN CALCIUM 173 168 12 19
FUROSEMIDE 172 147 13 8
FLUTICASONE PROPIONATE 159 140 14 27
METFORMIN HCL 151 147 15 7
TRAMADOL HCL 142 135 16 30
PRAVASTATIN SODIUM 140 131 17 18
BENAZEPRIL HCL 136 131 18 40
POTASSIUM CHLORIDE 133 125 19 20
CRESTOR 131 126 20 52
METOPROLOL SUCCINATE 127 121 21 22
LOSARTAN POTASSIUM 124 114 22 12
TAMSULOSIN HCL 121 121 23 25
METOPROLOL TARTRATE 116 106 24 9
PANTOPRAZOLE SODIUM 113 112 25 56
CITALOPRAM HBR 109 93 26 23
AMLODIPINE BESYLATE-BENAZEPRIL 108 108 27 108
ALENDRONATE SODIUM 102 102 28 16
LOVASTATIN 101 100 29 14
ATENOLOL 101 99 29 13
ADVAIR DISKUS 94 94 31 53
FINASTERIDE 89 89 32 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 72 33 24
TRIAMTERENE-HCTZ 79 73 34 49
ESTRADIOL 72 58 R 35 93
DIOVAN 66 66 36 69
TERAZOSIN HCL 58 58 37 38
ENALAPRIL MALEATE 56 54 38 77
HYDRALAZINE HCL 55 55 39 64
LOSARTAN-HYDROCHLOROTHIAZIDE 55 55 39 31
SYNTHROID 54 50 41 44
DONEPEZIL HCL 53 53 42 34
TRAZODONE HCL 52 48 43 47
BENAZEPRIL-HYDROCHLOROTHIAZIDE 51 51 44 179
LANSOPRAZOLE 50 49 45 228
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 23, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.